Investing.com - MorphoSys ADR reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
MorphoSys ADR announced earnings per share of €-3.07 on revenue of €58.16M. Analysts polled by Investing.com anticipated EPS of €-1.17 on revenue of €50.53M.
MorphoSys ADR shares are down 28.87% from the beginning of the year, still down 72.30% from its 52 week high of €24.19 set on May 3, 2021. They are under-performing the Nasdaq which is down 14.12% from the start of the year.
MorphoSys ADR follows other major Healthcare sector earnings this month
MorphoSys ADR's report follows an earnings matched by Medtronic on February 22, who reported EPS of €1.37 on revenue of €7.76B, compared to forecasts EPS of €1.37 on revenue of €7.88B.
Merck ADR had missed expectations on March 3 with first quarter EPS of €0.4558 on revenue of €5.77B, compared to forecast for EPS of €0.4818 on revenue of €5.88B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar